Xarelto Bleeding – The Trials Go On
- Last Updated: August 4th, 2023
Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
Legally Reviewed
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
Fact-Checked
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
Xarelto Bleeding – The Trials Go On
Despite a last ditch effort by the defendants to avoid another trip to court, Dora Mingo, who experienced a serious Xarelto bleeding event, will see her day in court.
The Honorable Eldon E. Fallon, Eastern District of Louisiana, ruled in favor of the plaintiffs last week denying a request for partial summary judgment by Janssen (a unit of Johnson & Johnson) and Bayer HealthCare Pharmaceuticals Inc.
Dora Mingo developed deep vein thrombosis (DVT) after having her hip replaced in 2015.
She was given Xarelto to treat the DVT.
Like many other individuals harmed by Xarelto, Mingo experienced uncontrollable bleeding that required hospitalization.
Mingo’s lawsuit alleges that Janssen and Bayer knew of the Xarelto bleeding events likelihood and did not warn patients or doctors.
There are more than 18,000 Xarelto bleeding lawsuits centralized in federal multidistrict litigation under the care of Judge Fallon in Lousiana.
Mingo’s case is serving as the third bellwether trial, selected by the court to be fully prepared and tried by a jury.
Mingo’s case is designed to help move along possible settlements for other individuals injured by Xarelto in order to avoid clogging the courts with 18,000 cases with similar facts – use of a common product, Xarelto, and common defendant, Janssen and Bayer.
Mingo is the third plaintiff to go to trial.
The two prior bellwether trials returned verdicts in favor of the defendants.
Partial summary judgment is a procedural device that is used during civil litigation to promptly dispose of an entire case without a trial.
It can be used either on the merits of the case or on discrete issues in the case.
By rejecting the request for partial summary judgment, Judge Fallon is indicating that Mingo’s case has legal merit and decision on whether Xarelto caused her DVT will be left to a jury.
We look forward to keeping TruLaw followers and clients updated as to the result of the third Xarelto bellwether case.
Table of Contents
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
AFFF Lawsuit claims are being filed against manufacturers of aqueous film-forming foam (AFFF), commonly used in firefighting.
Claims allege that companies such as 3M, DuPont, and Tyco Fire Products failed to adequately warn users about the potential dangers of AFFF exposure — including increased risks of various cancers and diseases.
Suboxone Tooth Decay Lawsuit claims are being filed against Indivior, the manufacturer of Suboxone, a medication used to treat opioid addiction.
Claims allege that Indivior failed to adequately warn users about the potential dangers of severe tooth decay and dental injuries associated with Suboxone’s sublingual film version.
Social Media Harm Lawsuits are being filed against social media companies for allegedly causing mental health issues in children and teens.
Claims allege that companies like Meta, Google, ByteDance, and Snap designed addictive platforms that led to anxiety, depression, and other mental health issues without adequately warning users or parents.
Transvaginal Mesh Lawsuits are being filed against manufacturers of transvaginal mesh products used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
Claims allege that companies like Ethicon, C.R. Bard, and Boston Scientific failed to adequately warn about potential dangers — including erosion, pain, and infection.
Bair Hugger Warming Blanket Lawsuits involve claims against 3M — alleging their surgical warming blankets caused severe infections and complications (particularly in hip and knee replacement surgeries).
Plaintiffs claim 3M failed to warn about potential risks — despite knowing about increased risk of deep joint infections since 2011.
Baby Formula NEC Lawsuit claims are being filed against manufacturers of cow’s milk-based baby formula products.
Claims allege that companies like Abbott Laboratories (Similac) and Mead Johnson & Company (Enfamil) failed to warn about the increased risk of necrotizing enterocolitis (NEC) in premature infants.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
